about
Levetiracetam therapy in patients with brain tumour and epilepsy.Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylationQuality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study.In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating centerEffect of high dose cytosine arabinoside on quantitative EEG in patients with acute myeloid leukemia.Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.Cognitive rehabilitation training in patients with brain tumor-related epilepsy and cognitive deficits: a pilot study.Weight of epilepsy in brain tumor patients.Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study.Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center.Nocturnal sleep and daytime somnolence in untreated patients with temporal lobe epilepsy: changes after treatment with controlled-release carbamazepine.Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy.Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy.Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme.Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.Reversible erectile dysfunction in a patient with brain tumor-related epilepsy in therapy with zonisamide in add-on.Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability.Multidrug resistance proteins expression in glioma patients with epilepsy.AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.Outcome and tolerability of topiramate in brain tumor associated epilepsy.Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study.Epilepsy in the end-of-life phase in patients with high-grade gliomas.Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life.Taking care of patients with brain tumor-related epilepsy: results from an Italian survey.Long-term administration of butoctamide hydrogen succinate on nocturnal sleep of mentally retarded subjects: a polygraphic study versus placebo.Rapidly progressive form of Creutzfeldt-Jakob disease without dementia: a case report.Zonisamide in Brain Tumor-Related Epilepsy: An Observational Pilot Study.Sodium valproate and mental processes in newly referred epileptic patients. A computerized EEG study.Spastic paraplegia, epilepsy, and mental retardation in several members of a family: a novel genetic disorder.EEG changes induced by carbamazepine therapy at rest and during mental processes.Sleep in healthy elderly subjects: a 24-hour ambulatory polysomnographic study.Trigeminal neuralgia as unusual isolated symptom of fungal paranasal sinusitis in patients with haematological malignancies.Temozolomide low-dose chemotherapy in newly diagnosed low-grade gliomas: activity, safety, and long-term follow-up.Prevention of Bortezomib-Related Peripheral Neuropathy With Docosahexaenoic Acid and α-Lipoic Acid in Patients With Multiple Myeloma: Preliminary DataLacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series studyCytomegalovirus encephalitis: diagnosis with clinical approach, EEG and PCR techniquesEffect of Carbamazepine on EEG Background Activity and on Interictal Epileptiform Abnormalities in Focal Epilepsy
P50
Q30483088-FA768A6D-F74E-43FB-B325-CC0E7239EBAEQ33383951-A233F85E-5F76-4521-A97A-A8C42EE76607Q33438914-D5ABAF45-2DE8-4885-8F5F-1536A2831D0CQ33768138-8057CA8D-1668-432A-9433-8694EA07E945Q34552757-72E21B6F-A573-43F6-A952-0123E25ED7B3Q36723848-66854CFD-3841-43EC-BC45-1EA5C27E1B8BQ38264990-3F0A52FD-F506-4C06-9E0B-75056026F7E7Q38721455-3CEFB8D2-6941-4211-BC61-39E6A95F6A53Q38964867-68E443DD-866E-4651-9458-B17AB6CEC917Q39199891-4D3158FA-12A5-4155-8D1F-BF8AABBCAD35Q39887655-D349DA11-8B08-4A70-B93F-8ABC2099BE5DQ41034651-E4CB1FEA-E781-4734-906D-B2A25BDFFD10Q42549143-A55E9527-D529-4205-9805-4D29CE149321Q42681369-6871E6FD-9621-48B8-8459-B2A6FCBCDAAAQ42976471-2A20F663-1DD5-4E38-9D06-C84AC27E4E1FQ43236058-F419ECF4-B3A6-43F8-B4B3-8DAD8A21F53EQ43257040-D48C0866-FB34-4127-8F58-22EB6A4C7F38Q43828519-2530E137-A626-426D-BB80-3F0D3CC8DB29Q45387609-14E41707-6F30-4D17-B7A1-D61FF06F7580Q46414107-44CBE939-1D41-4C91-9C22-AEC5C1126FA9Q47340679-57935C8C-218C-4D40-8399-CFE9EAEB2442Q47902006-4FFC8E39-58DC-49E3-A01A-1D855B9C1ED5Q48123337-60B7394F-0AAF-4E4A-82B6-88646CE03AD3Q48159289-C57CDACC-6D6E-441A-9EF8-769FF268D9ACQ48327187-6B87A353-4D13-48BF-81DC-EA3B53052D39Q48610473-A494B2F7-BDA0-461A-B947-6C941ED40C95Q48636460-BD8B0D88-42E3-4306-9BB9-F5E50B99654AQ48825815-8FDED2AA-BB5A-4F2A-97DC-1E0B2B59273DQ49140631-DA58D4F9-1433-4201-B129-C03B81FAE320Q50692926-32ADF20B-9B6E-4676-8E81-AD1429076EFBQ52020665-D9BD9833-5832-4EDD-B3AD-164C45A2078AQ52037328-A1F9682F-38DD-4BA2-B21F-455B7659AD00Q52040253-F4D504D9-431F-442A-B6C8-222EC50FCB6EQ52520397-C6B35CA4-822A-4E5A-9384-4B6931313D78Q53198358-8FEE0B86-2D95-4037-AB15-6C57F38357C1Q53559851-F2B69F6F-F71F-43FA-9CA8-9E56D8B8BE7DQ57181016-38DCD22F-CDF5-4469-840E-02DF9DBDCA4DQ58605524-E0FF4F0B-C326-4868-8191-32BA3A1387F0Q61479446-D27BAEEF-30DA-46EA-BEF2-39AD85860D1BQ61479451-4EFEB4C4-3B41-48AC-9ACF-42BE0C4F6269
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marta Maschio
@ast
Marta Maschio
@en
Marta Maschio
@es
Marta Maschio
@nl
Marta Maschio
@sl
type
label
Marta Maschio
@ast
Marta Maschio
@en
Marta Maschio
@es
Marta Maschio
@nl
Marta Maschio
@sl
prefLabel
Marta Maschio
@ast
Marta Maschio
@en
Marta Maschio
@es
Marta Maschio
@nl
Marta Maschio
@sl
P1053
H-8872-2017
P106
P21
P31
P3829
P496
0000-0002-3075-4108
P569
2000-01-01T00:00:00Z